ES2009757B3 - Procedimiento para la obtencion de gamma-butirolactamas. - Google Patents

Procedimiento para la obtencion de gamma-butirolactamas.

Info

Publication number
ES2009757B3
ES2009757B3 ES86113938T ES86113938T ES2009757B3 ES 2009757 B3 ES2009757 B3 ES 2009757B3 ES 86113938 T ES86113938 T ES 86113938T ES 86113938 T ES86113938 T ES 86113938T ES 2009757 B3 ES2009757 B3 ES 2009757B3
Authority
ES
Spain
Prior art keywords
butirolactamas
procedure
obtaining gamma
formula
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES86113938T
Other languages
English (en)
Inventor
Wolfgang Hartwig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chinese Academy of Medical Sciences CAMS
Bayer AG
Original Assignee
Chinese Academy of Medical Sciences CAMS
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinese Academy of Medical Sciences CAMS, Bayer AG filed Critical Chinese Academy of Medical Sciences CAMS
Application granted granted Critical
Publication of ES2009757B3 publication Critical patent/ES2009757B3/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/28—2-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

EN LA OXIDACION DE COMPUESTOS DE LA FORMULA II SE FORMAN DERIVADOS DE CLAUSENAMIDA DE LA FORMULA I. LOS COMPUESTOS DE LA FORMULA II SE OBTIENEN MEDIANTE UNA SINTESIS EN VARIAS ETAPAS.
ES86113938T 1985-10-18 1986-10-08 Procedimiento para la obtencion de gamma-butirolactamas. Expired ES2009757B3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3537074 1985-10-18
DE19863632589 DE3632589A1 (de) 1985-10-18 1986-09-25 Verfahren zur herstellung von (gamma)-butyrolactamen

Publications (1)

Publication Number Publication Date
ES2009757B3 true ES2009757B3 (es) 1989-10-16

Family

ID=25837071

Family Applications (1)

Application Number Title Priority Date Filing Date
ES86113938T Expired ES2009757B3 (es) 1985-10-18 1986-10-08 Procedimiento para la obtencion de gamma-butirolactamas.

Country Status (11)

Country Link
US (2) US4731455A (es)
EP (1) EP0222163B1 (es)
JP (2) JPH0794431B2 (es)
KR (1) KR870003980A (es)
CN (1) CN1019486B (es)
CA (1) CA1279650C (es)
DE (2) DE3632589A1 (es)
DK (1) DK498286A (es)
ES (1) ES2009757B3 (es)
HU (1) HU198450B (es)
IL (1) IL80305A (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3616989A1 (de) * 1986-05-21 1987-11-26 Bayer Ag Enantiomerenreine 4,5-disubstituierte (gamma)-butyrolactame, verfahren zu ihrer herstellung und ihre verwendung
DE3717394A1 (de) * 1987-05-23 1988-12-01 Basf Ag 3-phenyl-2-styryl-pyrrolidine, ihre herstellung und verwendung
DE3717395A1 (de) * 1987-05-23 1988-12-08 Basf Ag 5-phenyl-1,2,3a,4,5,9b-hexahydro-3h-benz(e) indole, ihre herstellung und verwendung als arzneimittel
EG18833A (en) * 1988-12-09 1994-11-30 Kumiai Chemical Industry Co Cyclic amide compounds and herbicides
DE3927370A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Verfahren zur herstellung von clausenamid und neoclausenamid und deren derivate
US6784167B2 (en) 2000-09-29 2004-08-31 Bayer Pharmaceuticals Corporation 17-beta-hydroxysteroid dehydrogenase-II inhibitors
US6787564B2 (en) * 2002-03-26 2004-09-07 Institute Of Materia Medica, Chinese Academy Of Medical Sciences Optically active clausenamides, process of the preparation thereof, pharmaceutical composition containing the same and their medical use
JP6059510B2 (ja) * 2012-11-05 2017-01-11 花王株式会社 セラミド産生促進剤

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT374457B (de) * 1977-08-18 1984-04-25 Hoechst Ag Verfahren zur herstellung von neuen benzolsulfonamidderivaten
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
US4454327A (en) * 1982-05-24 1984-06-12 Warner-Lambert Company 5-Oxo-2,2-pyrrolidinedipropanoic acid and ester derivatives thereof
DE3346623A1 (de) * 1983-12-14 1985-07-04 Bayer Ag, 5090 Leverkusen N-glycosylierte harnstoffe, carbamate und thiocarbamate, verfahren zu ihrer herstellung sowie ihre verwendung
DE3508025A1 (de) * 1985-03-07 1986-09-11 Bayer Ag, 5090 Leverkusen Substituierte o-sulfonyl-glycosylamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS61245606A (ja) * 1985-04-23 1986-10-31 Alps Electric Co Ltd マイクロ波発振器

Also Published As

Publication number Publication date
CA1279650C (en) 1991-01-29
DE3664464D1 (en) 1989-08-24
US4803285A (en) 1989-02-07
US4731455A (en) 1988-03-15
JPH0794431B2 (ja) 1995-10-11
DE3632589A1 (de) 1987-04-23
IL80305A (en) 1990-04-29
JPS62187451A (ja) 1987-08-15
CN86106592A (zh) 1987-06-03
EP0222163B1 (de) 1989-07-19
DK498286A (da) 1987-04-19
EP0222163A1 (de) 1987-05-20
JPH0853413A (ja) 1996-02-27
HU198450B (en) 1989-10-30
IL80305A0 (en) 1987-01-30
CN1019486B (zh) 1992-12-16
JP2520582B2 (ja) 1996-07-31
HUT46661A (en) 1988-11-28
DK498286D0 (da) 1986-10-17
KR870003980A (ko) 1987-05-06

Similar Documents

Publication Publication Date Title
IT1099106B (it) Sintesi di 2-cheto-1,4-diazacicloalcani
MX17846A (es) Proceso para la preparacion de nuevos derivados de 9h purina.
DK125179A (da) Fremgangsmaade til fremstilling af disubstituerede 3-cephem-4-catboxylsyrederivater
NO871939D0 (no) Fremgangsmaate for oeket ekspresjon av interleukin-2.
ES2009757B3 (es) Procedimiento para la obtencion de gamma-butirolactamas.
ES546625A0 (es) Procedimiento para la sintesis de derivados de acidos omega-aminados
IT7949530A0 (it) Procedimento per la produzione di 14,15-derivati metilenici della serie d'estrano
ES2038176T3 (es) Un procedimiento para la preparacion de derivados del naftaleno.
IT1132754B (it) Penam-derivati acetossimetilici come inibitori della beta-lattamasi
ES2037770T3 (es) Procedimiento para la preparacion de intermediarios para la sintesis de fosfomicina.
ES2038794T3 (es) Procedimiento para la obtencion de derivados del azolil-propenil- y azolilmetiloxirano y fungicidas que les contienen.
SE7510533L (sv) Hallare for turbindriven tandlekareborr
IT7850245A0 (it) Procedimento per la produzione di gas di sintesi mediante ossidazione parziale
FR2376846A1 (fr) Nouveaux derives de la piperidine
AR220120A1 (es) Procedimiento para la fabricacion de derivados de 1-alquil-4-(n-acetil)amino-tetrahidro-1,3,5-triazol-2,6-diona
ES2052925T3 (es) Compuestos de pirazol, metodo para su produccion, su uso, y compuestos intermedios para la produccion de los mismos.
GR1000887B (el) Νεα παραγωγα σπιροφουρανης.
IT7949087A0 (it) Procedimento per la sintesi di 2idrossi-3-metil ciclopent-2-en-1one
ES2138367T3 (es) Procedimiento para la fabricacion de agentes de contraste yodados.
AR222003A1 (es) Procedimiento para la preparacion de derivados de fenilpiperazina
IT1140506B (it) Procedimento di sintesi della vindesina
RO77308A (ro) Procedeu pentru prepararea derivatiilor aminochinazolinei substituite
MX4134E (es) Procedimiento para la preparacion de los compuestos 1,3-benzoditiol-2-tiona
IT7847813A0 (it) Metodo di sintesi per la preparazione della 3,4,5-trimetossibenzaldeide
IT8021128A0 (it) Composti a base di amidinouree per la cura della dismenorrea.